高精度经颅直流电刺激改善精神分裂症阴性症状的神经生理特征:TMS-EEG研究
该研究分两阶段:103例精神分裂症患者和76名健康对照接受TMS-EEG评估皮层兴奋/抑制,患者完成PANSS评估;随后患者双盲随机接受20次1.5mA阳极HD-tDCS靶向左侧DLPFC或伪刺激(活性52例、伪刺激51例)。活性HD-tDCS改善阴性、阳性和一般精神病理症状,伴N100正常化,且N100变化与阴性症状改善特异性相关。
要点
- 基线时患者N100波幅较健康对照降低(p=.005),且与阴性症状严重度相关(r=-0.28,p=.025)。
- 活性HD-tDCS改善阴性(d=-1.46)、阳性(d=-0.59)和一般精神病理(d=-1.13)症状。
- N100正常化(p=.013)且其变化与阴性症状改善特异性相关(p=.01),可能作为治疗反应标志。
核心结论
- 左侧DLPFC靶向HD-tDCS可改善精神分裂症阴性症状,可能通过恢复皮层抑制功能实现。
- N100正常化可能是治疗反应的神经生理标志,探索性证据提示前额-边缘网络可塑性可能参与其中。
研究设计与样本
- 研究分两阶段:第一阶段纳入103例精神分裂症患者和76名健康对照,进行TMS-EEG评估皮层兴奋与抑制,患者完成PANSS评估。
- 第二阶段为双盲随机对照试验:患者随机接受20次1.5-mA阳极HD-tDCS靶向左侧DLPFC或伪刺激(活性52例、伪刺激51例),干预后行TMS-EEG。
主要发现
- 基线时患者N100波幅较健康对照降低(p=.005),且与阴性症状严重度相关(r=-0.28,p=.025)。
- 活性HD-tDCS改善阴性症状(d=-1.46)、阳性症状(d=-0.59)和一般精神病理症状(d=-1.13)。
- 活性HD-tDCS后N100正常化(p=.013),N100变化与阴性症状改善特异性相关(p=.01),与其他症状域无关。
- 探索性源空间分析显示活性HD-tDCS后边缘网络电流密度显著增加且与症状相关(p=.04),但未通过错误发现率校正。
关键数值与推荐
- HD-tDCS参数:1.5-mA阳极,靶向左侧DLPFC,共20次。
- 活性HD-tDCS组52例,伪刺激组51例。
临床怎么用
- 左侧DLPFC靶向HD-tDCS可能作为改善精神分裂症阴性症状的干预选项。
- N100正常化或可作为评估治疗反应的神经生理标志,但需进一步验证。
局限性
- 探索性源空间分析结果未通过错误发现率校正,前额-边缘网络可塑性证据仅为初步。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Schizophrenia (SCZ) remains a major health challenge, partly because conventional antipsychotics show limited efficacy for negative symptoms. High-definition transcranial direct current stimulation (HD-tDCS) may improve these symptoms; however, its neurophysiological mechanisms remain unclear. METHODS: This study included two phases. First, 103 patients with SCZ and 76 healthy control (HC) participants underwent transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) to assess cortical excitation and inhibition; patients also completed Positive and Negative Syndrome Scale assessments. Second, patients were randomized in a double-blind trial to receive 20 sessions of 1.5-mA anodal HD-tDCS targeting the left dorsolateral prefrontal cortex (DLPFC) or sham stimulation (active: 52; sham: 51), followed by postintervention TMS-EEG. RESULTS: At baseline, patients showed reduced N100 amplitudes compared with HC participants (p = .005), which correlated with negative symptom severity (r = -0.28, p = .025). Active HD-tDCS improved negative (d = -1.46), positive (d = -0.59), and general psychopathology (d = -1.13) symptoms. These improvements were accompanied by N100 normalization (p = .013), and N100 changes were specifically associated with negative symptom improvement (p = .01) but not with other symptom domains. Exploratory source-space analyses showed limbic-network significant current density increases and symptom associations after active HD-tDCS (p = .04), but these effects did not survive false discovery rate correction. CONCLUSIONS: Left DLPFC-targeted HD-tDCS improves negative symptoms in SCZ, potentially by restoring cortical inhibitory function, with exploratory evidence suggesting possible involvement of prefrontal-limbic network plasticity. N100 normalization may represent a signature of treatment response.
引用
- Chen M, Li D, Zhu R, et al. Neurophysiological Signatures of Negative Symptom Improvement After High-Definition Transcranial Direct Current Stimulation: A Transcranial Magnetic Stimulation-Electroencephalography Study. Biol Psychiatry. 2026. PMID: 42705493. doi:10.1016/j.biopsych.2026.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。